Summary & Overview
HCPCS C1875: Stent, Coated/Covered, Without Delivery System
HCPCS Level II code C1875 identifies a coated or covered vascular stent supplied without a delivery system. The code covers the physical implantable device used in endovascular procedures to scaffold and seal blood vessels. Nationally, device-specific coding like C1875 matters for device tracking, hospital supply billing, and payer coverage policies for vascular interventions.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find operational benchmarks and payer coverage considerations, clinical context around device use in endovascular procedures, and common billing considerations tied to coding a stent that is billed separately from its delivery system. The publication outlines where C1875 is typically applied (inpatient and outpatient vascular procedure settings) and highlights the implications for facility billing, supply charge capture, and payer adjudication. Where specific payer policies or fee benchmarks are not provided in the source input, the text notes that those data are not available in the input. The material is intended to inform coding staff, revenue cycle managers, and clinicians involved in vascular device procurement and billing about the role and typical use of HCPCS Level II code C1875 at a national level.
Billing Code Overview
HCPCS Level II code C1875 describes a stent, coated/covered, without delivery system. This item represents a vascular implant intended to maintain vessel patency and provide a coated or covered surface, supplied separately from any delivery catheter or deployment system.
Service Type: Implantable vascular device
Typical Site of Service: Inpatient or outpatient vascular procedure settings, including hospital operating rooms, cardiac catheterization laboratories, and outpatient surgical centers where the stent is implanted during endovascular procedures.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic peripheral arterial disease or coronary artery disease requiring placement of a covered (coated) stent without an accompanying delivery system. The patient presents with recurrent ischemic symptoms (e.g., claudication, rest pain, acute coronary syndrome) or evidence of significant vessel restenosis/aneurysm on imaging. The clinical workflow begins with diagnostic assessment (history, physical exam, vascular imaging such as angiography, CTA, or duplex ultrasound), anticoagulation/antiplatelet planning, and informed consent. In the procedure room or catheterization lab, an interventional cardiologist or vascular surgeon gains endovascular access, performs angiography, and prepares the vessel. The covered stent (C1875) is selected and used when a covered scaffold is required to exclude a vessel wall defect (e.g., perforation, pseudoaneurysm), seal a dissection, or treat in-stent restenosis or aneurysmal disease. Because C1875 specifies the stent without the delivery system, device and supply charges are documented separately from procedural services and any delivery system or catheterization codes. Post-deployment angiography confirms stent position and vessel patency. The patient is monitored in a recovery or observation area; typical sites of service include the inpatient operating room, outpatient ambulatory surgical center, or hospital-based catheterization lab depending on acuity and complexity. Documentation must clearly distinguish the implanted device (C1875) from the professional procedural service when billing; applicable modifiers should be appended to the procedure CPT code(s) as indicated by clinical circumstances.
Coding Specifications
| Modifier | Description |
|---|